Brian F. King - Publications

Publications (43)

XB-PERS-3180

Publications By Brian F. King

???pagination.result.count???

???pagination.result.page??? 1

Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors., Wildman SS, Boone M, Peppiatt-Wildman CM, Contreras-Sanz A, King BF, Shirley DG, Deen PM, Unwin RJ., J Am Soc Nephrol. July 1, 2009; 20 (7): 1480-90.
Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors., Asatryan L, Popova M, Woodward JJ, King BF, Alkana RL, Davies DL., Neuropharmacology. October 1, 2008; 55 (5): 835-43.
P2X receptor signaling inhibits BDNF-mediated spiral ganglion neuron development in the neonatal rat cochlea., Greenwood D, Jagger DJ, Huang LC, Hoya N, Thorne PR, Wildman SS, King BF, Pak K, Ryan AF, Housley GD., Development. April 1, 2007; 134 (7): 1407-17.
Regulatory interdependence of cloned epithelial Na+ channels and P2X receptors., Wildman SS, Marks J, Churchill LJ, Peppiatt CM, Chraibi A, Shirley DG, Horisberger JD, King BF, Unwin RJ., J Am Soc Nephrol. September 1, 2005; 16 (9): 2586-97.
Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes., Davies DL, Kochegarov AA, Kuo ST, Kulkarni AA, Woodward JJ, King BF, Alkana RL., Neuropharmacology. August 1, 2005; 49 (2): 243-53.
Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red., King BF, Liu M, Townsend-Nicholson A, Pfister J, Padilla F, Ford AP, Gever JR, Oglesby IB, Schorge S, Burnstock G., Br J Pharmacol. June 1, 2005; 145 (3): 313-22.
Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions., Wildman SS, Unwin RJ, King BF., Br J Pharmacol. December 1, 2003; 140 (7): 1177-86.
Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1)., Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, Unwin RJ, King BF., Mol Pharmacol. October 1, 2002; 62 (4): 957-66.
Heteromultimeric P2X(1/2) receptors show a novel sensitivity to extracellular pH., Brown SG, Townsend-Nicholson A, Jacobson KA, Burnstock G, King BF., J Pharmacol Exp Ther. February 1, 2002; 300 (2): 673-80.
Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety., Cinkilic O, King BF, van der Giet M, Schlüter H, Zidek W, Burnstock G., J Pharmacol Exp Ther. October 1, 2001; 299 (1): 131-6.
Actions of a Series of PPADS Analogs at P2X1 and P2X3 Receptors., Brown SG, Kim YC, Kim SA, Jacobson KA, Burnstock G, King BF., Drug Dev Res. August 1, 2001; 53 (4): 281-291.
Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons., Liu M, King BF, Dunn PM, Rong W, Townsend-Nicholson A, Burnstock G., J Pharmacol Exp Ther. March 1, 2001; 296 (3): 1043-50.
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors., Kim YC, Brown SG, Harden TK, Boyer JL, Dubyak G, King BF, Burnstock G, Jacobson KA., J Med Chem. February 1, 2001; 44 (3): 340-9.
In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors., Jacobson KA, Kim YC, King BF., J Auton Nerv Syst. July 3, 2000; 81 (1-3): 152-7.
Diinosine pentaphosphate: an antagonist which discriminates between recombinant P2X(3) and P2X(2/3) receptors and between two P2X receptors in rat sensory neurones., Dunn PM, Liu M, Zhong Y, King BF, Burnstock G., Br J Pharmacol. July 1, 2000; 130 (6): 1378-84.
Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes., King BF, Townsend-Nicholson A, Wildman SS, Thomas T, Spyer KM, Burnstock G., J Neurosci. July 1, 2000; 20 (13): 4871-7.
Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors., Brown SG, King BF, Kim YC, Jang SY, Burnstock G, Jacobson KA., Drug Dev Res. April 1, 2000; 49 (4): 253-259.
Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors., King BF, Liu M, Pintor J, Gualix J, Miras-Portugal MT, Burnstock G., Br J Pharmacol. November 1, 1999; 128 (5): 981-8.
Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors., Wildman SS, King BF, Burnstock G., Br J Pharmacol. September 1, 1999; 128 (2): 486-92.
Selectivity of diadenosine polyphosphates for rat P2X receptor subunits., Wildman SS, Brown SG, King BF, Burnstock G., Eur J Pharmacol. February 12, 1999; 367 (1): 119-23.
Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors., Townsend-Nicholson A, King BF, Wildman SS, Burnstock G., Brain Res Mol Brain Res. February 5, 1999; 64 (2): 246-54.
Modulation of ATP-responses at recombinant rP2X4 receptors by extracellular pH and zinc., Wildman SS, King BF, Burnstock G., Br J Pharmacol. February 1, 1999; 126 (3): 762-8.
Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists., Kim YC, Camaioni E, Ziganshin AU, Ji XD, King BF, Wildman SS, Rychkov A, Yoburn J, Kim H, Mohanram A, Harden TK, Boyer JL, Burnstock G, Jacobson KA., Drug Dev Res. October 1, 1998; 45 (2): 52-66.
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors., Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, Boyer JL, King BF, Burnstock G., J Med Chem. June 18, 1998; 41 (13): 2201-6.
Molecular cloning and characterization of rat P2Y4 nucleotide receptor., Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G., Br J Pharmacol. June 1, 1998; 124 (3): 428-30.
Antagonism of an adenosine/ATP receptor in follicular Xenopus oocytes., King BF, Wildman SS, Townsend-Nicholson A, Burnstock G., J Pharmacol Exp Ther. June 1, 1998; 285 (3): 1005-11.
Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH., Wildman SS, King BF, Burnstock G., Br J Pharmacol. March 1, 1998; 123 (6): 1214-20.
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor., King BF, Wildman SS, Ziganshina LE, Pintor J, Burnstock G., Br J Pharmacol. August 1, 1997; 121 (7): 1445-53.
Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos., Bogdanov YD, Dale L, King BF, Whittock N, Burnstock G., J Biol Chem. May 9, 1997; 272 (19): 12583-90.
Potentiation of ATP-responses at a recombinant P2x2 receptor by neurotransmitters and related substances., Wildman SS, King BF, Burnstock G., Br J Pharmacol. January 1, 1997; 120 (2): 221-4.
Peptidyl conjugates of adenosine 5'-carboxylic acid synthesized and evaluated as ligands for P2 purinoceptors., Järlebark L, Erlandsson M, Uri A, King BF, Ziganshin AU, Johansson C, Heilbronn E., Biochem Biophys Res Commun. December 13, 1996; 229 (2): 363-9.
Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors., Pintor J, King BF, Miras-Portugal MT, Burnstock G., Br J Pharmacol. November 1, 1996; 119 (5): 1006-12.
P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies., King BF, Neary JT, Zhu Q, Wang S, Norenberg MD, Burnstock G., Neuroscience. October 1, 1996; 74 (4): 1187-96.
Differential degradation of extracellular adenine nucleotides by folliculated oocytes of Xenopus laevis., Ziganshin AU, Ziganshina LE, King BF, Burnstock G., Comp Biochem Physiol A Physiol. August 1, 1996; 114 (4): 335-40.
A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates., Webb TE, Henderson D, King BF, Wang S, Simon J, Bateson AN, Burnstock G, Barnard EA., Mol Pharmacol. August 1, 1996; 50 (2): 258-65.
P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis., King BF, Wang S, Burnstock G., J Physiol. July 1, 1996; 494 ( Pt 1) 17-28.
Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis., Ziganshin AU, Ziganshina LE, King BF, Pintor J, Burnstock G., Biochem Pharmacol. April 12, 1996; 51 (7): 897-901.
Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH., King BF, Ziganshina LE, Pintor J, Burnstock G., Br J Pharmacol. April 1, 1996; 117 (7): 1371-3.
Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor., King BF, Dacquet C, Ziganshin AU, Weetman DF, Burnstock G, Vanhoutte PM, Spedding M., Br J Pharmacol. March 1, 1996; 117 (6): 1111-8.
Diadenosine polyphosphate-activated inward and outward currents in follicular oocytes of Xenopus laevis., Pintor J, King BF, Ziganshin AU, Miras-Portugal MT, Burnstock G., Life Sci. January 1, 1996; 59 (12): PL179-84.
A novel P1 purinoceptor activates an outward K+ current in follicular oocytes of Xenopus laevis., King BF, Pintor J, Wang S, Ziganshin AU, Ziganshina LE, Burnstock G., J Pharmacol Exp Ther. January 1, 1996; 276 (1): 93-100.
Characterisation of a recombinant P2Y purinoceptor., Simon J, Webb TE, King BF, Burnstock G, Barnard EA., Eur J Pharmacol. November 30, 1995; 291 (3): 281-9.
Cloning and functional expression of a brain G-protein-coupled ATP receptor., Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA., FEBS Lett. June 14, 1993; 324 (2): 219-25.

Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors., Wildman SS, Boone M, Peppiatt-Wildman CM, Contreras-Sanz A, King BF, Shirley DG, Deen PM, Unwin RJ., J Am Soc Nephrol. July 1, 2009; 20 (7): 1480-90.

Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors., Asatryan L, Popova M, Woodward JJ, King BF, Alkana RL, Davies DL., Neuropharmacology. October 1, 2008; 55 (5): 835-43.

P2X receptor signaling inhibits BDNF-mediated spiral ganglion neuron development in the neonatal rat cochlea., Greenwood D, Jagger DJ, Huang LC, Hoya N, Thorne PR, Wildman SS, King BF, Pak K, Ryan AF, Housley GD., Development. April 1, 2007; 134 (7): 1407-17.

Regulatory interdependence of cloned epithelial Na+ channels and P2X receptors., Wildman SS, Marks J, Churchill LJ, Peppiatt CM, Chraibi A, Shirley DG, Horisberger JD, King BF, Unwin RJ., J Am Soc Nephrol. September 1, 2005; 16 (9): 2586-97.

Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes., Davies DL, Kochegarov AA, Kuo ST, Kulkarni AA, Woodward JJ, King BF, Alkana RL., Neuropharmacology. August 1, 2005; 49 (2): 243-53.

Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red., King BF, Liu M, Townsend-Nicholson A, Pfister J, Padilla F, Ford AP, Gever JR, Oglesby IB, Schorge S, Burnstock G., Br J Pharmacol. June 1, 2005; 145 (3): 313-22.

Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions., Wildman SS, Unwin RJ, King BF., Br J Pharmacol. December 1, 2003; 140 (7): 1177-86.

Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1)., Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, Unwin RJ, King BF., Mol Pharmacol. October 1, 2002; 62 (4): 957-66.

Heteromultimeric P2X(1/2) receptors show a novel sensitivity to extracellular pH., Brown SG, Townsend-Nicholson A, Jacobson KA, Burnstock G, King BF., J Pharmacol Exp Ther. February 1, 2002; 300 (2): 673-80.

Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety., Cinkilic O, King BF, van der Giet M, Schlüter H, Zidek W, Burnstock G., J Pharmacol Exp Ther. October 1, 2001; 299 (1): 131-6.

Actions of a Series of PPADS Analogs at P2X1 and P2X3 Receptors., Brown SG, Kim YC, Kim SA, Jacobson KA, Burnstock G, King BF., Drug Dev Res. August 1, 2001; 53 (4): 281-291.

Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts generates heterogeneous populations of P2X receptors that evoke a spectrum of agonist responses comparable to that seen in sensory neurons., Liu M, King BF, Dunn PM, Rong W, Townsend-Nicholson A, Burnstock G., J Pharmacol Exp Ther. March 1, 2001; 296 (3): 1043-50.

Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors., Kim YC, Brown SG, Harden TK, Boyer JL, Dubyak G, King BF, Burnstock G, Jacobson KA., J Med Chem. February 1, 2001; 44 (3): 340-9.

In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors., Jacobson KA, Kim YC, King BF., J Auton Nerv Syst. July 3, 2000; 81 (1-3): 152-7.

Diinosine pentaphosphate: an antagonist which discriminates between recombinant P2X(3) and P2X(2/3) receptors and between two P2X receptors in rat sensory neurones., Dunn PM, Liu M, Zhong Y, King BF, Burnstock G., Br J Pharmacol. July 1, 2000; 130 (6): 1378-84.

Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes., King BF, Townsend-Nicholson A, Wildman SS, Thomas T, Spyer KM, Burnstock G., J Neurosci. July 1, 2000; 20 (13): 4871-7.

Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors., Brown SG, King BF, Kim YC, Jang SY, Burnstock G, Jacobson KA., Drug Dev Res. April 1, 2000; 49 (4): 253-259.

Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors., King BF, Liu M, Pintor J, Gualix J, Miras-Portugal MT, Burnstock G., Br J Pharmacol. November 1, 1999; 128 (5): 981-8.

Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors., Wildman SS, King BF, Burnstock G., Br J Pharmacol. September 1, 1999; 128 (2): 486-92.

Selectivity of diadenosine polyphosphates for rat P2X receptor subunits., Wildman SS, Brown SG, King BF, Burnstock G., Eur J Pharmacol. February 12, 1999; 367 (1): 119-23.

Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors., Townsend-Nicholson A, King BF, Wildman SS, Burnstock G., Brain Res Mol Brain Res. February 5, 1999; 64 (2): 246-54.

Modulation of ATP-responses at recombinant rP2X4 receptors by extracellular pH and zinc., Wildman SS, King BF, Burnstock G., Br J Pharmacol. February 1, 1999; 126 (3): 762-8.

Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists., Kim YC, Camaioni E, Ziganshin AU, Ji XD, King BF, Wildman SS, Rychkov A, Yoburn J, Kim H, Mohanram A, Harden TK, Boyer JL, Burnstock G, Jacobson KA., Drug Dev Res. October 1, 1998; 45 (2): 52-66.

A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors., Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, Boyer JL, King BF, Burnstock G., J Med Chem. June 18, 1998; 41 (13): 2201-6.

Molecular cloning and characterization of rat P2Y4 nucleotide receptor., Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G., Br J Pharmacol. June 1, 1998; 124 (3): 428-30.

Antagonism of an adenosine/ATP receptor in follicular Xenopus oocytes., King BF, Wildman SS, Townsend-Nicholson A, Burnstock G., J Pharmacol Exp Ther. June 1, 1998; 285 (3): 1005-11.

Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH., Wildman SS, King BF, Burnstock G., Br J Pharmacol. March 1, 1998; 123 (6): 1214-20.

Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor., King BF, Wildman SS, Ziganshina LE, Pintor J, Burnstock G., Br J Pharmacol. August 1, 1997; 121 (7): 1445-53.

Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos., Bogdanov YD, Dale L, King BF, Whittock N, Burnstock G., J Biol Chem. May 9, 1997; 272 (19): 12583-90.

Potentiation of ATP-responses at a recombinant P2x2 receptor by neurotransmitters and related substances., Wildman SS, King BF, Burnstock G., Br J Pharmacol. January 1, 1997; 120 (2): 221-4.

Peptidyl conjugates of adenosine 5'-carboxylic acid synthesized and evaluated as ligands for P2 purinoceptors., Järlebark L, Erlandsson M, Uri A, King BF, Ziganshin AU, Johansson C, Heilbronn E., Biochem Biophys Res Commun. December 13, 1996; 229 (2): 363-9.

Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors., Pintor J, King BF, Miras-Portugal MT, Burnstock G., Br J Pharmacol. November 1, 1996; 119 (5): 1006-12.

P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies., King BF, Neary JT, Zhu Q, Wang S, Norenberg MD, Burnstock G., Neuroscience. October 1, 1996; 74 (4): 1187-96.

Differential degradation of extracellular adenine nucleotides by folliculated oocytes of Xenopus laevis., Ziganshin AU, Ziganshina LE, King BF, Burnstock G., Comp Biochem Physiol A Physiol. August 1, 1996; 114 (4): 335-40.

A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates., Webb TE, Henderson D, King BF, Wang S, Simon J, Bateson AN, Burnstock G, Barnard EA., Mol Pharmacol. August 1, 1996; 50 (2): 258-65.

P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis., King BF, Wang S, Burnstock G., J Physiol. July 1, 1996; 494 ( Pt 1) 17-28.

Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis., Ziganshin AU, Ziganshina LE, King BF, Pintor J, Burnstock G., Biochem Pharmacol. April 12, 1996; 51 (7): 897-901.

Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH., King BF, Ziganshina LE, Pintor J, Burnstock G., Br J Pharmacol. April 1, 1996; 117 (7): 1371-3.

Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor., King BF, Dacquet C, Ziganshin AU, Weetman DF, Burnstock G, Vanhoutte PM, Spedding M., Br J Pharmacol. March 1, 1996; 117 (6): 1111-8.

Diadenosine polyphosphate-activated inward and outward currents in follicular oocytes of Xenopus laevis., Pintor J, King BF, Ziganshin AU, Miras-Portugal MT, Burnstock G., Life Sci. January 1, 1996; 59 (12): PL179-84.

A novel P1 purinoceptor activates an outward K+ current in follicular oocytes of Xenopus laevis., King BF, Pintor J, Wang S, Ziganshin AU, Ziganshina LE, Burnstock G., J Pharmacol Exp Ther. January 1, 1996; 276 (1): 93-100.

Characterisation of a recombinant P2Y purinoceptor., Simon J, Webb TE, King BF, Burnstock G, Barnard EA., Eur J Pharmacol. November 30, 1995; 291 (3): 281-9.

Cloning and functional expression of a brain G-protein-coupled ATP receptor., Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA., FEBS Lett. June 14, 1993; 324 (2): 219-25.

???pagination.result.page??? 1